JG
ATOS icon

Jain Global’s Atossa Therapeutics ATOS Stock Holding History

Jain Global’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,114
Closed -$14.5K – 1222
2025
Q3 		$14.5K Sell
1,114
-7,090
-86% -$87.6K ﹤0.01% 967
2025
Q2 		$102K Buy
+8,204
New +$98.1K ﹤0.01% 1033

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jain Global's ATOS Position: Q4 2025 in Review

Jain Global sold out of Atossa Therapeutics (ATOS) in Q4 2025, closing a stake of 1,114 shares — an estimated $14.5K sold.

Jain Global first reported a position in ATOS in Q2 2025 and held it in 2 quarters. The position peaked at $102K in Q2 2025. 67 funds tracked by Wall St. Rank hold ATOS as of Q4 2025.

  • Jain Global reported no remaining Atossa Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Jain Global sold 1,114 Atossa Therapeutics shares in Q4 2025, an estimated $14.5K.
  • Jain Global first reported a position in Atossa Therapeutics in Q2 2025 and held it in 2 quarters.
  • Jain Global's Atossa Therapeutics position peaked at $102K in Q2 2025.
  • 67 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q4 2025.

Based on Jain Global's 13F filing for Q4 2025, filed 17 Feb 2026.